Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients

PURPOSE: Immunotherapy using immune checkpoint inhibitors (ICI) has revolutionized cancer treatment in recent years, particularly in melanoma. While response to immunotherapy is associated with high tumor mutational burden (TMB), PD-L1 expression, and microsatellite instability in several cancers, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Freiberger, Sandra N., Holzmann, David, Morand, Grégoire B., Hüllner, Martin, Levesque, Mitchell P., Dummer, Reinhard, Koelzer, Viktor H., Rupp, Niels J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356647/
https://www.ncbi.nlm.nih.gov/pubmed/36527482
http://dx.doi.org/10.1007/s00432-022-04514-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356647/
https://www.ncbi.nlm.nih.gov/pubmed/36527482
http://dx.doi.org/10.1007/s00432-022-04514-z

Ejemplares similares